2020
DOI: 10.1016/j.jad.2019.12.009
|View full text |Cite
|
Sign up to set email alerts
|

Cognitive changes after tDCS and escitalopram treatment in major depressive disorder: Results from the placebo-controlled ELECT-TDCS trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(4 citation statements)
references
References 50 publications
0
4
0
Order By: Relevance
“…This exploratory treatment has been tested widely for the treatment of major depressive disorder (MDD) [ 10 13 ]. Both clinical trials and systematic reviews with meta-analyses have shown that tDCS not only has the potential to improve mood symptoms in depressive patients [ 11 , 14 , 15 ] but is also able to enhance cognitive functions [ 16 18 ]. TDCS showed potential in patients with bipolar disorder in a major depressive episode [ 19 21 ] and postpartum depression [ 22 ], as well as in adult [ 23 , 24 ] and elderly [ 25 ] populations.…”
Section: Introductionmentioning
confidence: 99%
“…This exploratory treatment has been tested widely for the treatment of major depressive disorder (MDD) [ 10 13 ]. Both clinical trials and systematic reviews with meta-analyses have shown that tDCS not only has the potential to improve mood symptoms in depressive patients [ 11 , 14 , 15 ] but is also able to enhance cognitive functions [ 16 18 ]. TDCS showed potential in patients with bipolar disorder in a major depressive episode [ 19 21 ] and postpartum depression [ 22 ], as well as in adult [ 23 , 24 ] and elderly [ 25 ] populations.…”
Section: Introductionmentioning
confidence: 99%
“…For instance, Bennabi et al evaluated neuropsychological outcomes after an observational follow-up period of 30 days (Bennabi et al, 2015) and observed no differences between baseline and follow-up measures. Although tDCS appears to be cognitively safe in the acute treatment of depression (Martin et al, 2018;Moreno et al, 2020) and may actually improve cognitive performance in depressed patients after a course of the treatment (Salehinejad et al, 2015), its cognitive effects after long-term application are still unknown and future trials must be conducted in order to more accurately demonstrate these effects.…”
Section: Discussionmentioning
confidence: 99%
“…Among these configurations, bilateral DLPFC with the cathode on the right DLPFC (F4) is one of the most common montages. This tDCS montage has proven effective in treating depression (46)(47)(48), schizophrenia (49), addiction (50,51), ADHD (52), and anxiety (53). Notably, evidence suggests that alterations in FSPV interneurons may play a crucial role in the pathophysiology of these disorders (54)(55)(56).…”
Section: Introductionmentioning
confidence: 99%